PMDD (Premenstrual Dysphoric Disorder) is one of the few psychiatric conditions where intermittent medication dosing has substantial evidence. Unlike depression or anxiety — where continuous treatment is the standard — PMDD can be effectively treated with SSRIs given only during the luteal phase of the menstrual cycle. This unique treatment option matters for women who don’t want continuous medication.
According to research summarized by the American College of Obstetricians and Gynecologists, both luteal-phase and continuous SSRI strategies are evidence-based for PMDD — with each having advantages depending on patient circumstances.
Why PMDD Treatment Differs from Standard Depression
PMDD is biologically tied to the menstrual cycle — symptoms emerge in the luteal phase (after ovulation) and resolve within days of menstruation onset. This pattern allows treatment approaches not possible with other mood disorders:
- Symptoms have predictable onset and offset
- Trigger (progesterone metabolite sensitivity) is identifiable
- SSRIs work much faster in PMDD than in depression (days, not weeks)
- Intermittent dosing can produce sustained response
Treatment Options
Continuous SSRI dosing
Daily SSRI throughout the cycle. Effective for 60-70% of PMDD patients. Particularly useful when:
- Patient has coexisting depression or anxiety
- Cycle tracking is difficult
- Symptoms aren’t perfectly cyclical
- Patient prefers consistent dosing
Luteal-phase only dosing
SSRI started 14 days before expected menses, continued through Day 1 of menses. Effective for many PMDD patients with similar response rates to continuous dosing.
Advantages:
- Reduced total medication exposure
- Lower side effect burden over time
- Avoidance of long-term SSRI use for women who prefer this
- Useful for women planning pregnancy
Requires reliable cycle tracking. Less practical for women with irregular cycles.
Symptom-onset dosing
SSRI started when symptoms begin each cycle, continued until menses. Useful when symptom timing varies.
Specific SSRI considerations
- Sertraline — FDA-approved for PMDD; commonly used; flexible dosing
- Fluoxetine — FDA-approved for PMDD as Sarafem; long half-life makes it forgiving
- Paroxetine — FDA-approved for PMDD; effective but withdrawal symptoms can be challenging with intermittent use
- Escitalopram — Off-label but commonly used; well-tolerated
When SSRIs Don’t Provide Adequate Response
SNRI options
Venlafaxine has evidence for PMDD when SSRIs haven’t worked. Duloxetine may also help.
Hormonal options
Some women benefit from hormonal suppression of ovulation:
- Continuous oral contraceptives — eliminate cycle by suppressing ovulation
- Drospirenone-containing OCs — specifically studied for PMDD
- GnRH agonists — chemical menopause; reserved for severe cases
- Oophorectomy — surgical option only for the most severe, treatment-refractory cases after careful consideration
Augmentation strategies
Calcium supplementation, chasteberry, vitamin B6 — modest evidence, sometimes useful adjuncts.
Lifestyle factors
Exercise, sleep, stress management, alcohol reduction — meaningful for many women, though insufficient alone for severe PMDD.
Source: ACOG and clinical research on PMDD treatment.
Tracking Matters
Effective PMDD treatment requires:
- Confirmed diagnosis via prospective tracking (2+ cycles)
- Cycle tracking to enable luteal-phase dosing
- Symptom tracking to assess treatment response
- Recognition of break-through cycles needing adjustment
Apps like Daysy, Clue, or DRSP rating scales work well for systematic tracking.
Generic depression treatment
PMDD often gets treated like generic depression — missing PMDD-specific strategies that could work better with less medication exposure.
PMDD-specific strategies
Dr. Farkas matches treatment to patient circumstances — including intermittent dosing for women who prefer it.
Effective, individualized care
PMDD-specific treatment produces dramatic improvement for most women — often dramatically changing quality of life.
Common Questions About PMDD Treatment
Will I have to take medication every day?
Not necessarily — luteal-phase dosing is a valid option for many women. Continuous or intermittent both work; selection depends on your situation.
How quickly does luteal-phase dosing work?
SSRIs work much faster in PMDD than in depression — often within 2-3 days. By the second or third cycle of treatment, most patients see substantial response.
Can I get pregnant while on PMDD treatment?
Yes — most SSRIs are compatible with pregnancy planning. Discuss specific medication choice with your provider. See our related articles on PMDD basics and perinatal mental health.
What about hormonal options?
For some women, continuous OCs or other hormonal approaches work well — particularly when SSRIs haven’t provided adequate response. Decision involves coordination with gynecology.